Direct-to-consumer advertising: The future in Europe

Food and Drug Administration. Direct-to-consumer advertising of prescription drugs: withdrawal of moratorium. Fed Register 1985; 50: 36677–8

Wolfe SM. Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? Characteristics of materials distributed by drug companies: four points of view. J Gen Intern Med 1996; 11: 637–9

Wilkes MS , Bell RA , Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact and implications. Health Affairs 2000; 19: 110–28

Firn D. Companies selling medical products on the web will need to focus their strategies around the end-user. Financial Times 3 February, 2000

Martin P. Evaluating the tests for prescription advertising. Financial Times 28 October, 1999

McKechnie S. Advertising by pharmaceutical companies in eBMJ. BMJ 1999; 318: 598

ABPI. Medicines Control Agency v Bristol-Myers Squibb. Internet sit. Code of Practice Review 1999; (November):73-8

Holmer AF. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA 1999; 281: 380–2

Spurgeon D. Doctors feel pressurised by direct to consumer advertising. BMJ 1999; 319: 1321

Lipsky MS , Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract 1997; 45: 495–9

Sullivan DL , Schommer JC , Birdell SW. Consumer retention of risk information from direct-to-consumer advertising. Drug Info J 1999; 33: 281–9

Tanouye E. Drug ads spur patients to demand more prescriptions. Wall Street J 22 December, 1997:B1

National Health Service Executive. A Guide to Consent for Examination and Treatment. Leeds: NHS Executive, 1990

Collier J. Patient-information leaflets and prescriber competence. Lancet 1998; 352: 1724

Council on Scientific Affairs and Council on Ethical and Judicial Affairs. Conflicts of interest in medical center/industry research relationships. JAMA 1990; 263: 2790–3

Sergeant MD , Hodgetts PG , Godwin M , Walker DM , McHenry P. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. Can Med Assoc J 1996; 155: 1243–8

Hollon MF. Direct-to-consumer marketing of prescription drugs. JAMA 1999; 281: 382–4

Freeman L. Aggressive strategy helps propel Claritin to top slot. Advertising Age 1998; 69: 6–7

Shock M. Medicine at the centre of the nation's affairs. BMJ 1994; 309: 1730–3